Arisawa M, Ohshima J, Ohsawa E, Maruyama H B
Antimicrob Agents Chemother. 1982 May;21(5):706-10. doi: 10.1128/AAC.21.5.706.
Potentiating activity of alafosfalin was examined in detail with 8 cephalosporins and mecillinam against 164 urinary bacteria representing 8 genera. Alafosfalin was generally comparable in activity to cefamandole and mecillinam but superior to other cephalosporins tested. When the minimal fractional inhibitory concentration indices were compared, synergism was observed with all of the beta-lactams tested for all species except Streptococcus faecalis. Marked synergism was observed with Escherichia coli, Citrobacter, and enterobacter and, among the drugs tested, with cefamandole and mecillinam. Although alafosfalin is inactive against Pseudomonas aeruginosa, potentiation was seen with cefsulodin. The most favorable combination ratio of alafosfalin/cephalosporin to elicit potentiation was determined for each species and occurred in a rather narrow range of combinations (1:4 to 4:1 in general).
对阿拉磷增强8种头孢菌素和美西林对代表8个菌属的164株尿路细菌活性的作用进行了详细研究。阿拉磷的活性一般与头孢孟多和美西林相当,但优于所测试的其他头孢菌素。当比较最小抑菌浓度分数指数时,除粪肠球菌外,对所有测试物种的所有β-内酰胺类药物均观察到协同作用。对大肠杆菌、柠檬酸杆菌和肠杆菌观察到明显的协同作用,在所测试的药物中,与头孢孟多和美西林观察到明显的协同作用。虽然阿拉磷对铜绿假单胞菌无活性,但与磺苄西林联合使用时可见增效作用。确定了每种细菌产生增效作用时阿拉磷/头孢菌素的最适宜组合比例,且该比例出现在相当窄的组合范围内(一般为1:4至4:1)。